The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).
Jul 12, 2024
0
1
More than 2,400 patients at hospitals around Portland, Oregon, may have been exposed to infectious diseases such as hepatitis B and C, as well as HIV, because of an anesthesiologist who may not have followed infection control ...
Jul 12, 2024
0
0
Physical therapy can be a life changer, helping people address chronic pain, recovery from surgery or injury, or getting back to a beloved sport. But that's only if physical therapy is done—and done right.
Jul 12, 2024
0
0
A new study has found that an artificial intelligence (AI) conversational agent enhances patient care after cataract surgery. The AI-powered automated voice system, called Dora, is able to call patients to ask them questions, ...
Jul 11, 2024
0
24
A multi-institutional study found that 1 in 6 youths fill an opioid prescription prior to surgery, and 3% of patients were still filling opioid prescriptions three to six months after surgery, indicating persistent opioid ...
Jul 11, 2024
0
0
In Rhode Island, over one in four emergency department (ED) patients at high risk of overdose has a non-fatal opioid overdose in the 18 months after discharge.
Jul 11, 2024
0
7
Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were ...
Jul 11, 2024
0
6
Inequities in pain medication treatment received postpartum, after giving birth, were found in a Cedars-Sinai study of 18,000 women. The disparities were observed even among patients reporting the highest pain levels.
Jul 11, 2024
0
0
Compared with their urban counterparts, rural residents with head and neck cancer (HNC) have higher mortality rates and less annual improvement, according to a research letter published online June 27 in JAMA Otolaryngology-Head ...
Jul 11, 2024
0
0
A new study has revealed significant discrepancies in the prescription of COVID-19 antivirals, indicating that many patients may not have received the most effective treatment available.
Jul 11, 2024
0
0
